Rock Creek Pharmaceuticals Inc (fka RCPIQ)

[leifsmith]

This study is significant, I think. Gives a reason for optimism in human trials.

Title: Anatabine Ameliorates Experimental Autoimmune Thyroiditis
Publication: Endocrinology

A pre-clinical investigator-initiated and independently funded study from Johns Hopkins University researchers examined the effect of anatabine supplementation in a mouse model of autoimmune thyroiditis. The results were published in September 2012 in an article entitled, “Anatabine Ameliorates Experimental Autoimmune Thyroiditis” in the Endocrine Society’s journal, Endocrinology. (Endocrinology. 2012 Sep; 153(9):4580-7.)

LINK: http://dx.doi.org/10.1210/en.2012-1452